{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:19:46Z","timestamp":1790518786306,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016M2C2A1937988"],"award-info":[{"award-number":["NRF-2016M2C2A1937988"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016M2B2A4909218"],"award-info":[{"award-number":["NRF-2016M2B2A4909218"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017M2B2A4042384"],"award-info":[{"award-number":["NRF-2017M2B2A4042384"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bmcl.2018.01.060","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T11:46:14Z","timestamp":1517485574000},"page":"915-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Acetazolamide-based [18F]-PET tracer: In vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors"],"prefix":"10.1016","volume":"28","author":[{"given":"Kunal N.","family":"More","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam-Chul","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoung","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misun","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangseok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Jo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2018.01.060_b0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia-a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmcl.2018.01.060_b0010","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2018.01.060_b0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmcl.2018.01.060_h0020","doi-asserted-by":"crossref","first-page":"129S","DOI":"10.2967\/jnumed.107.045914","article-title":"Molecular imaging of hypoxia","volume":"49","author":"Krohn","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2018.01.060_h0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00330-006-0431-y","article-title":"Imaging oxygenation of human tumours","volume":"17","author":"Padhani","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bmcl.2018.01.060_h0030","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1259\/bjr\/17904358","article-title":"Hypoxia in head and neck cancer","volume":"79","author":"Isa","year":"2006","journal-title":"Br J Radiol"},{"key":"10.1016\/j.bmcl.2018.01.060_b0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrg2665","article-title":"Generating specificity and diversity in the transcriptional response to hypoxia","volume":"10","author":"Lendahl","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bmcl.2018.01.060_b0030","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bmcl.2018.01.060_b0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/med.20112","article-title":"Carbonic anhydrase IX: a new druggable target for the design of antitumor agents","volume":"28","author":"Winum","year":"2008","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2018.01.060_b0040","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M800938200","article-title":"Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes","volume":"283","author":"Hilvo","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2018.01.060_b0045","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.bjc.6605690","article-title":"High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer","volume":"102","author":"Ilie","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmcl.2018.01.060_b0050","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2001.19.16.3660","article-title":"Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma","volume":"19","author":"Chia","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bmcl.2018.01.060_b0055","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2018.01.060_h0070","first-page":"802","article-title":"Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy","volume":"9","author":"Bui","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2018.01.060_h0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2010.03.015","article-title":"Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy","volume":"58","author":"Stillebroer","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.bmcl.2018.01.060_b0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5306\/wjco.v3.i7.98","article-title":"Inhibition of carbonic anhydrase IX as a novel anticancer mechanism","volume":"3","author":"Supuran","year":"2012","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.bmcl.2018.01.060_h0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-8-1","article-title":"Carbonic anhydrase IX in oligodendroglial brain tumors","volume":"8","author":"Jarvela","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bmcl.2018.01.060_h0090","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.2174\/138161210793429788","article-title":"Modulation of carbonic anhydrase 9 (CA9) in human brain cancer","volume":"16","author":"Harun","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmcl.2018.01.060_b0075","first-page":"3399","article-title":"Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy","volume":"7","author":"Koukourakis","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2018.01.060_b0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.bjc.6600936","article-title":"Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer","volume":"89","author":"Potter","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmcl.2018.01.060_h0105","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2018.01.060_h0110","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2018.01.060_b0090","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.bmcl.2009.06.022","article-title":"In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives","volume":"19","author":"Ahlskog","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.01.060_b0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget."},{"key":"10.1016\/j.bmcl.2018.01.060_b0100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2018.01.060_b0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2018.01.060_h0135","doi-asserted-by":"crossref","first-page":"36139","DOI":"10.18632\/oncotarget.5684","article-title":"Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo","volume":"6","author":"Guan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2018.01.060_h0140","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/acs.molpharmaceut.5b00934","article-title":"PET imaging of carbonic anhydrase IX expression of HT-29 tumor xenograft mice with 68Ga-labeled benzenesulfonamides","volume":"13","author":"Lau","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2018.01.060_h0145","article-title":"Trimeric 18F-AmBF3-sulfonamides for imaging carbonic anhydrase IX expression","volume":"56","author":"Lau","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2018.01.060_h0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/146164a0","article-title":"Sulphanilamide as a specific inhibitor of carbonic anhydrase","volume":"146","author":"Mann","year":"1940","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2018.01.060_h0155","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/ja01167a011","article-title":"The Preparation of heterocyclic sulfonamides1","volume":"72","author":"Roblin","year":"1950","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2018.01.060_b0120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CRD.0b013e31822b4939","article-title":"Acetazolamide: a forgotten diuretic agent","volume":"19","author":"Kassamali","year":"2011","journal-title":"Cardiol Rev."},{"key":"10.1016\/j.bmcl.2018.01.060_b0125","doi-asserted-by":"crossref","first-page":"36666","DOI":"10.18632\/oncotarget.9134","article-title":"Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors","volume":"7","author":"Faes","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2018.01.060_b0130","first-page":"745","article-title":"Acetazolamide suppresses tumor metastasis and related protein expression in mice bearing Lewis lung carcinoma","volume":"23","author":"Xiang","year":"2002","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bmcl.2018.01.060_b0135","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2967\/jnumed.115.170514","article-title":"A 99mTc-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo","volume":"57","author":"Krall","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2018.01.060_h0180","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/anie.201310709","article-title":"A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors","volume":"53","author":"Krall","year":"2014","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2018.01.060_h0185","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1158\/1535-7163.MCT-16-0283","article-title":"Acetazolamide serves as selective delivery vehicle for dipeptide-linked drugs to renal cell carcinoma","volume":"15","author":"Cazzamalli","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2018.01.060_h0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.urolonc.2009.03.028","article-title":"Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and 124I-cG250 PET\/CT","volume":"29","author":"Lawrentschuk","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.bmcl.2018.01.060_h0195","first-page":"510","article-title":"ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice","volume":"28","author":"Stillebroer","year":"2013","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.bmcl.2018.01.060_h0200","series-title":"Carbonic anhydrase: mechanism, regulation, links to disease, and industrial applications","first-page":"255","article-title":"Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells","author":"McDonald","year":"2014"},{"key":"10.1016\/j.bmcl.2018.01.060_h0205","doi-asserted-by":"crossref","first-page":"e50860","DOI":"10.1371\/journal.pone.0050860","article-title":"In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia","volume":"7","author":"Bao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2018.01.060_b0155","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2217\/fon.15.11","article-title":"Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?","volume":"11","author":"Li","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.bmcl.2018.01.060_b0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fonc.2016.00069","article-title":"Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis","volume":"6","author":"Van Kuijk","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2018.01.060_b0165","doi-asserted-by":"crossref","first-page":"16186","DOI":"10.3390\/molecules200916186","article-title":"Methods to increase the metabolic stability of 18F-radiotracers","volume":"20","author":"Kuchar","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2018.01.060_b0170","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1021\/jm5012935","article-title":"Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates","volume":"57","author":"Moeker","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.060_b0175","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.060_b0180","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.060_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-538","article-title":"The potential of hypoxia markers as target for breast molecular imaging \u2013 a systematic review and meta-analysis of human marker expression","volume":"13","author":"Adams","year":"2013","journal-title":"BMC Cancer"}],"updated-by":[{"DOI":"10.1016\/j.bmcl.2018.06.020","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000}}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18300714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18300714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:22:24Z","timestamp":1760772144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X18300714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0960894X18300714"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.060","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bmcl.2018.06.020","asserted-by":"object"}]},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetazolamide-based [18F]-PET tracer: In vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}